The Inhibition Effect of Lactobacilli Against Growth and Biofilm Formation of Pseudomonas aeruginosa
- PMID: 28293865
- DOI: 10.1007/s12602-017-9267-9
The Inhibition Effect of Lactobacilli Against Growth and Biofilm Formation of Pseudomonas aeruginosa
Abstract
The emergence of antibiotic-resistant and food-spoilage microorganisms has renewed efforts to identify safe and natural alternative agents of antibiotics such as probiotics. The aim of this study was the isolation of lactobacilli as potential probiotics from local dairy products with broad antibacterial and anti-biofilm activities against antibiotic-resistant strains of Pseudomonas aeruginosa and determination of their inhibition mechanism. Antibiotic susceptibility and classification of acquired resistance profiles of 80 P. aeruginosa strains were determined based on Centers for Disease Control and Prevention (CDC) new definition as multidrug-resistant (MDR), extensively drug-resistant (XDR), and pan-drug-resistant (PDR) followed by antibacterial assessment of lactobacilli against them by different methods. Among the 80 P. aeruginosa strains, 1 (1.3%), 50 (62.5%), and 78 (97.5%) were PDR, XDR, and MDR, respectively, and effective antibiotics against them were fosfomycin and polymyxins. Among 57 isolated lactobacillus strains, two strains which were identified as Lactobacillus fermentum using biochemical and 16S rDNA methods showed broad inhibition/killing and anti-biofilm effects against all P. aeruginosa strains. They formed strong biofilms and had bile salts and low pH tolerance. Although investigation of inhibition mechanism of these strains showed no bacteriocin production, results obtained by high-performance liquid chromatography (HPLC) analysis indicated that their inhibitory effect was the result of production of three main organic acids including lactic acid, acetic acid, and formic acid. Considering the broad activity of these two L. fermentum strains, they can potentially be used in bio-control of drug-resistant strains of P. aeruginosa.
Keywords: Antibiotic resistance; Lactobacilli; Multidrug-resistant (MDR); Probiotic; Pseudomonas aeruginosa.
Similar articles
-
Evaluating the anti-biofilm and antibacterial effects of Juglans regia L. extracts against clinical isolates of Pseudomonas aeruginosa.Microb Pathog. 2018 May;118:285-289. doi: 10.1016/j.micpath.2018.03.055. Epub 2018 Mar 29. Microb Pathog. 2018. PMID: 29605650
-
Phenotypic characterization of multidrug-resistant Pseudomonas aeruginosa strains isolated from pediatric patients associated to biofilm formation.Microbiol Res. 2015 Mar;172:68-78. doi: 10.1016/j.micres.2014.11.005. Epub 2014 Dec 5. Microbiol Res. 2015. PMID: 25530579
-
Evaluation of chlorogenic acid and carnosol for anti-efflux pump and anti-biofilm activities against extensively drug-resistant strains of Staphylococcus aureus and Pseudomonas aeruginosa.Microbiol Spectr. 2024 Sep 3;12(9):e0393423. doi: 10.1128/spectrum.03934-23. Epub 2024 Jul 24. Microbiol Spectr. 2024. PMID: 39046262 Free PMC article.
-
Role of probiotics in the prevention and treatment of meticillin-resistant Staphylococcus aureus infections.Int J Antimicrob Agents. 2013 Dec;42(6):475-81. doi: 10.1016/j.ijantimicag.2013.08.003. Epub 2013 Sep 7. Int J Antimicrob Agents. 2013. PMID: 24071026 Review.
-
PLGA-Based Nanoplatforms in Drug Delivery for Inhibition and Destruction of Microbial Biofilm.Front Cell Infect Microbiol. 2022 Jun 21;12:926363. doi: 10.3389/fcimb.2022.926363. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35800390 Free PMC article. Review.
Cited by
-
Oral probiotic activities and biosafety of Lactobacillus gasseri HHuMIN D.Microb Cell Fact. 2021 Mar 23;20(1):75. doi: 10.1186/s12934-021-01563-w. Microb Cell Fact. 2021. PMID: 33757506 Free PMC article.
-
Evaluation of commercial probiotic lactic cultures against biofilm formation by Cronobacter sakazakii.Intest Res. 2019 Apr;17(2):192-201. doi: 10.5217/ir.2018.00106. Epub 2018 Dec 3. Intest Res. 2019. PMID: 30508474 Free PMC article.
-
Endotracheal tube microbiome in hospitalized patients defined largely by hospital environment.Respir Res. 2022 Jun 24;23(1):168. doi: 10.1186/s12931-022-02086-7. Respir Res. 2022. PMID: 35751068 Free PMC article.
-
Distinct antibiotic treatment regimens differentially affect colonization resistance against multi-drug resistant Pseudomonas aeruginosa in mice.Eur J Microbiol Immunol (Bp). 2025 Apr 14;15(2):125-136. doi: 10.1556/1886.2025.00015. Print 2025 Jun 30. Eur J Microbiol Immunol (Bp). 2025. PMID: 40227851 Free PMC article.
-
Interplay of Mycobacterium abscessus and Pseudomonas aeruginosa in experimental models of coinfection: Biofilm dynamics and host immune response.Virulence. 2025 Dec;16(1):2493221. doi: 10.1080/21505594.2025.2493221. Epub 2025 May 8. Virulence. 2025. PMID: 40237819 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources